<DOC>
	<DOCNO>NCT02835625</DOCNO>
	<brief_summary>Compare digital breast tomosynthesis ( DBT ) digital mammography ( DM ) screen tool woman age 50-69 year , invite participate Norwegian Breast Cancer Screening Program screen unit Bergen , Norway , regard early performance measure , include prognostic predictive tumor characteristic , radiation dos cost-effectiveness .</brief_summary>
	<brief_title>The Tomosynthesis Trial Bergen</brief_title>
	<detailed_description>DBT new screen tool , argue well standard DM . This statement base low recall rate , high rate early-stage screen-detected cancer . No study far report result woman screen DBT GE Healthcare , far investigator know . DBT GE offer synthetic two-dimensional DM generate DBT data ( 2D ) , study show similar detection rate technique adjacent DM . By compare result early performance measure economic aspect two comparable population woman age group , reside county , investigator measure effect 2D+DBT ( tomo ) versus standard DM equipment GE Healthcare . The population examine radiographer , screen-read radiologist , histologically breast cancer proven pathologist , treat surgeon oncologist . A prospective cohort study target 45,000 woman invite breast cancer screen Bergen , Hordaland study period , 2016-2018 , perform . A screening participation approximately 75 % expect . All attend woman ask willing participate study receive write oral information study . Women willing participate study sign inform consent . Of attend woman expect 90-95 % consent participate study . The woman randomize two group , study group control group . The randomization take place screen unit Bergen . The outcome randomization base 11-digit personal identification number assign every citizen Norway . In study group , woman screen tomo . In control group , woman screen DM . Women willing participate study screen DM , include study . The investigator aim address follow topic research question : - Study 1 : Early performance measure population base screen program use tomo versus DM - interim analysis . - Study 2 : Use tomo versus DM population base screen program - randomize controlled trial . - Study 3 : Prognostic predictive histopathologic characteristic breast tumor detect population base program use tomo versus DM . - Study 4 : Tomo DM population base screen program - technology high sensitivity woman mammographic dense breast ? - Study 5 6 : Costs tomo DM population base screen program - tomo cost-effective ?</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Informed consent Breast prosthesis</criteria>
	<gender>Female</gender>
	<minimum_age>48 Years</minimum_age>
	<maximum_age>71 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Diagnostic Imaging</keyword>
	<keyword>Mammography</keyword>
	<keyword>Randomized Controlled Trial</keyword>
	<keyword>Tomosynthesis</keyword>
	<keyword>Early performance measure</keyword>
	<keyword>Recall</keyword>
	<keyword>Radiation dose</keyword>
	<keyword>Cancer detection</keyword>
	<keyword>Sensitivity</keyword>
	<keyword>Specificity</keyword>
	<keyword>Cost</keyword>
	<keyword>Economy</keyword>
</DOC>